Disease | vascular disease |
Phenotype | C0409974|lupus erythematosus |
Sentences | 15 |
PubMedID- 22126778 | Objective: to investigate the prevalence of cardiovascular diseases (cvd) in patients with systemic lupus erythematosus (sle) and estimate the associated risk factors for cvd. |
PubMedID- 26167325 | vascular disease is frequent in patients with systemic lupus erythematosus and represents the most frequent cause of death in established disease. |
PubMedID- 25732129 | Methods: forty systemic lupus erythematosus women with cardiovascular disease (systemic lupus erythematosus cases), 40 systemic lupus erythematosus women without cardiovascular disease, and 40 healthy controls were enrolled in this study. |
PubMedID- 22401784 | Subclinical vascular disease in patients with systemic lupus erythematosus: the additive deleterious effect of the antiphospholipid syndrome. |
PubMedID- 24470118 | 25-hydroxyvitamin d and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. |
PubMedID- 22957213 | vascular disease is frequent in patients with systemic lupus erythematosus and represents the most frequent cause of death in established disease. |
PubMedID- 21360503 | Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation. |
PubMedID- 24787906 | Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus. |
PubMedID- 23886740 | Background and purpose: antiphospholipid syndrome may affect the incidence and pathogenesis of cerebrovascular diseases in patients with systemic lupus erythematosus. |
PubMedID- 20191526 | Objective: to investigate the association between physical activity, functional activity of high-density lipoprotein (hdl), and subclinical cardiovascular disease in patients with systemic lupus erythematosus (sle). |
PubMedID- 23612403 | [cerebrovascular disease in women with systemic lupus erythematosus]. |
PubMedID- 25379191 | Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus. |
PubMedID- 23052654 | Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus. |
PubMedID- 23942785 | Increased serum levels of s100a8/a9 and s100a12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus. |
PubMedID- PMC3467499 | Our study investigates whether serum α-clfa may be a biomarker for subclinical cardiovascular disease (cvd) in patients with systemic lupus erythematosus (sle). |
Page: 1